250 related articles for article (PubMed ID: 25310132)
1. The AIDS response catalysing economic and social transformation: the importance of local pharmaceutical production.
Sidibé M
Antivir Ther; 2014; 19 Suppl 3():3-4. PubMed ID: 25310132
[No Abstract] [Full Text] [Related]
2. Production of antiretroviral drugs in middle- and low-income countries.
Pinheiro Edos S; Brüning K; Macedo MF; Siani AC
Antivir Ther; 2014; 19 Suppl 3():49-55. PubMed ID: 25310755
[TBL] [Abstract][Full Text] [Related]
3. The discovery and development of antiretroviral agents.
Lange JM; Ananworanich J
Antivir Ther; 2014; 19 Suppl 3():5-14. PubMed ID: 25310317
[TBL] [Abstract][Full Text] [Related]
4. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.
Orsi F; D'Almeida C; Hasenclever L; Camara M; Tigre P; Coriat B
AIDS; 2007 Oct; 21(15):1997-2003. PubMed ID: 17885289
[No Abstract] [Full Text] [Related]
5. Production of low cost AIDS drugs to continue in Brazil.
Reprod Health Matters; 2001 Nov; 9(18):178. PubMed ID: 11803899
[No Abstract] [Full Text] [Related]
6. Active pharmaceutical ingredients for antiretroviral treatment in low- and middle-income countries: a survey.
Fortunak JM; de Souza RO; Kulkarni AA; King CL; Ellison T; Miranda LS
Antivir Ther; 2014; 19 Suppl 3(0 3):15-29. PubMed ID: 25310430
[TBL] [Abstract][Full Text] [Related]
7. Intellectual property rights, market competition and access to affordable antiretrovirals.
Pascual F
Antivir Ther; 2014; 19 Suppl 3():57-67. PubMed ID: 25309984
[TBL] [Abstract][Full Text] [Related]
8. Low-cost generic drugs under the President's Emergency Plan for AIDS Relief drove down treatment cost; more are needed.
Venkatesh KK; Mayer KH; Carpenter CC
Health Aff (Millwood); 2012 Jul; 31(7):1429-38. PubMed ID: 22778332
[TBL] [Abstract][Full Text] [Related]
9. Hope for South Africa--at last.
Lancet; 2003 Aug; 362(9383):501. PubMed ID: 12932376
[No Abstract] [Full Text] [Related]
10. Working together to provide generics for health.
Beck EJ; Reiss P
Antivir Ther; 2014; 19 Suppl 3():1. PubMed ID: 25310234
[No Abstract] [Full Text] [Related]
11. Dispatches from the front line.
Nature; 2002 Aug; 418(6897):465. PubMed ID: 12152038
[No Abstract] [Full Text] [Related]
12. World Trade Organization still threatens supply of affordable AIDS drugs.
Hagmann M
Bull World Health Organ; 2002; 80(9):762-3. PubMed ID: 12378300
[No Abstract] [Full Text] [Related]
13. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after.
Cohen J
Science; 2006 Jul; 313(5786):484-7. PubMed ID: 16873654
[No Abstract] [Full Text] [Related]
14. Trans-Pacific trade pact triggers fears over drug prices.
McCall C
Lancet; 2015 Jun; 385(9986):2450-1. PubMed ID: 26122057
[No Abstract] [Full Text] [Related]
15. Indian company seeks US approval for generic AIDS drugs.
Nature; 2004 Aug; 430(7001):716. PubMed ID: 15306779
[No Abstract] [Full Text] [Related]
16. Access to HIV drugs: are we changing the two world paradigm?
Lazzarini Z
Conn J Int Law; 2002; 17(2):281-96. PubMed ID: 12688297
[No Abstract] [Full Text] [Related]
17. Do patents prevent access to drugs for HIV in developing countries?
Selgelid MJ; Schuklenk U
JAMA; 2002 Feb; 287(7):842-3. PubMed ID: 11851570
[No Abstract] [Full Text] [Related]
18. Do patents prevent access to drugs for HIV in developing countries?
Goemaere E; Kaninda AV; Ciaffi L; Mulemba M; t Hoen E; Pécoul B
JAMA; 2002 Feb; 287(7):841-2; author reply 842-3. PubMed ID: 11851569
[No Abstract] [Full Text] [Related]
19. Canada's plan to sell generic drugs to developing countries is threatened.
Spurgeon D
BMJ; 2004 Mar; 328(7442):728. PubMed ID: 15044278
[No Abstract] [Full Text] [Related]
20. Affordable drug access for developing countries.
Highleyman L
BETA; 2001; 14(2):12-25. PubMed ID: 11785481
[No Abstract] [Full Text] [Related]
[Next] [New Search]